Medications for Human Immunodeficiency Virus I Infection

18 results

  • apretude - cabotegravir

    (Cabotegravir)
    Viiv Healthcare Company
    Apretude is used for pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 infection in adults and adolescents weighing at least 35 kg who are at risk. A negative HIV-1 test is required before starting.
    Medication Details

  • complera - emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate tablet, film coated

    (Emtricitabine, Rilpivirine Hydrochloride, And Tenofovir Disoproxil Fumarate)
    Gilead Sciences, Inc.
    Complera is a complete antiretroviral regimen for treating HIV-1 infection in adults and children weighing at least 35 kg. Used as initial therapy in treatment-naive patients with HIV-1 RNA ≤100,000 copies/mL, or to replace a stable regimen in virologically suppressed patients.
    Medication Details
    Drug Interactions

  • delstrigo - doravirine, lamivudine, and tenofovir disoproxil fumarate tablet, film coated

    (Doravirine, Lamivudine, And Tenofovir Disoproxil Fumarate)
    Merck Sharp & Dohme Llc
    Delstrigo is a complete HIV-1 treatment regimen for adults and pediatric patients weighing at least 35 kg. Used in treatment-naive patients or to replace a stable antiretroviral regimen in those with suppressed HIV-1 RNA and no history of treatment failure.
    Medication Details
    Drug Interactions

  • descovy - emtricitabine and tenofovir alafenamide tablet

    (Emtricitabine And Tenofovir Alafenamide)
    Gilead Sciences, Inc.
    DESCOVY treats HIV-1 infection in adults and adolescents (≥35 kg) and pediatric patients (14–35 kg) in combination with other antiretrovirals. Also indicated as pre-exposure prophylaxis (PrEP) to reduce HIV-1 risk from sexual acquisition in at-risk adults and adolescents ≥35 kg, excluding receptive vaginal sex.
    Medication Details
    Drug Interactions

  • edurant - rilpivirine hydrochloride tablet, film coated

    (Rilpivirine Hydrochloride)
    Janssen Products, Lp
    Edurant treats HIV-1 infection in treatment-naïve patients age 2+ weighing ≥14 kg with viral load ≤100,000 copies/mL, combined with other antiretrovirals. Also used short-term with cabotegravir in virologically suppressed adults and adolescents (12+, ≥35 kg) as oral lead-in or bridge for injectable CABENUVA.
    Medication Details
    Drug Interactions

  • evotaz - atazanavir and cobicistat tablet

    (Atazanavir And Cobicistat)
    E.R. Squibb & Sons, L.L.C.
    EVOTAZ combines atazanavir (HIV-1 protease inhibitor) and cobicistat (CYP3A inhibitor) for treating HIV-1 infection in adults and pediatric patients weighing at least 35 kg, used alongside other antiretroviral agents. Treatment-experienced patients should be guided by baseline protease inhibitor resistance substitutions.
    Medication Details
    Drug Interactions

  • fuzeon - enfuvirtide

    (Enfuvirtide)
    Genentech, Inc.
    Fuzeon, combined with other antiretroviral agents, treats HIV-1 infection in treatment-experienced adults with ongoing HIV-1 replication despite current antiretroviral therapy.
    Medication Details
    Drug Interactions

  • genvoya - elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide tablet

    (Elvitegravir, Cobicistat, Emtricitabine, And Tenofovir Alafenamide)
    Gilead Sciences, Inc.
    Genvoya is a complete HIV-1 treatment regimen for adults and children weighing at least 25 kg, used in treatment-naive patients or to replace current therapy in those virologically suppressed on stable antiretrovirals for at least 6 months with no treatment failure or resistance history.
    Medication Details
    Drug Interactions

  • isentress - raltegravir tablet, film coated

    (Raltegravir)
    Merck Sharp & Dohme Llc
    ISENTRESS and ISENTRESS HD treat HIV-1 infection in adults and children, used in combination with other antiretroviral agents. ISENTRESS is approved for pediatric patients weighing at least 2 kg; ISENTRESS HD for those weighing at least 40 kg.
    Medication Details
    Drug Interactions